Wintrust Investments LLC Bristol Myers Squibb CO Transaction History

Wintrust Investments LLC

$123 Million
Q3 2024

A detailed history of Wintrust Investments LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wintrust Investments LLC holds 3,934 shares of BMY stock, worth $231,594. This represents 0.17% of its overall portfolio holdings.

Number of Shares

3,934

Previous 43,785 91.02%

Holding current value

$231,594

Previous $1.82 Million 88.83%

% of portfolio

0.17%

Previous 0.16%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$39.66 - $51.75 $1.58 Million - $2.06 Million	-39,851 Reduced 91.02%	3,934 $203,000
Q2 2024 Aug 13, 2024	BUY	$40.25 - $52.99 $166,353 - $219,007	4,133 Added 10.42%	43,785 $1.82 Million
Q1 2024 May 09, 2024	BUY	$47.98 - $54.4 $168,649 - $191,216	3,515 Added 9.73%	39,652 $2.15 Million
Q4 2023 Feb 12, 2024	SELL	$48.48 - $57.85 $2.1 Million - $2.5 Million	-43,289 Reduced 54.5%	36,137 $1.85 Million
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $3.64 Million - $4.07 Million	-62,833 Reduced 44.17%	79,426 $4.61 Million
Q2 2023 Aug 10, 2023	SELL	$63.71 - $70.74 $1.65 Million - $1.83 Million	-25,911 Reduced 15.41%	142,259 $9.1 Million
Q1 2023 May 09, 2023	BUY	$65.71 - $74.53 $1.79 Million - $2.03 Million	27,173 Added 19.27%	168,170 $11.7 Million
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $306,379 - $362,796	-4,474 Reduced 3.08%	140,997 $10.1 Million
Q3 2022 Nov 08, 2022	SELL	$0.13 - $76.84 $31 - $18,518	-241 Reduced 0.17%	145,471 $10.3 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $8.55 Million - $9.41 Million	117,692 Added 420.03%	145,712 $11.2 Million
Q1 2022 May 11, 2022	BUY	$61.48 - $73.72 $29,694 - $35,606	483 Added 1.75%	28,020 $2.05 Million
Q4 2021 Feb 04, 2022	SELL	$53.63 - $62.52 $15,713 - $18,318	-293 Reduced 1.05%	27,537 $1.72 Million
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $19,289 - $22,595	326 Added 1.19%	27,830 $1.65 Million
Q2 2021 Aug 10, 2021	SELL	$61.91 - $67.42 $11,948 - $13,012	-193 Reduced 0.7%	27,504 $1.84 Million
Q1 2021 May 10, 2021	BUY	$59.34 - $66.74 $1.64 Million - $1.85 Million	27,697 New	27,697 $1.75 Million
Q4 2020 Feb 08, 2021	SELL	$57.74 - $65.43 $1.62 Million - $1.84 Million	-28,051 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $83,158 - $92,150	-1,448 Reduced 4.91%	28,051 $1.69 Million
Q2 2020 Aug 07, 2020	BUY	$54.82 - $64.09 $355,946 - $416,136	6,493 Added 28.22%	29,499 $1.74 Million
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $13,456 - $19,554	-290 Reduced 1.24%	23,006 $1.28 Million
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $55,459 - $72,342	-1,127 Reduced 4.61%	23,296 $1.5 Million
Q3 2019 Nov 07, 2019	SELL	$42.77 - $50.71 $213,165 - $252,738	-4,984 Reduced 16.95%	24,423 $1.24 Million
Q2 2019 Aug 05, 2019	SELL	$44.62 - $49.34 $1.63 Million - $1.8 Million	-36,476 Reduced 55.36%	29,407 $0
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $50,399 - $60,094	-1,117 Reduced 1.67%	65,883 $3.14 Million
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $757,584 - $982,404	-15,537 Reduced 18.82%	67,000 $3.48 Million
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $71,139 - $80,240	-1,289 Reduced 1.54%	82,537 $5.12 Million
Q2 2018 Aug 13, 2018	BUY	$50.53 - $62.98 $3.74 Million - $4.66 Million	73,942 Added 748.1%	83,826 $4.64 Million
Q1 2018 May 03, 2018	SELL	$59.92 - $68.98 $151,777 - $174,726	-2,533 Reduced 20.4%	9,884 $625,000
Q4 2017 Feb 13, 2018	BUY	$59.94 - $65.35 $33,086 - $36,073	552 Added 4.65%	12,417 $761,000
Q3 2017 Nov 07, 2017	BUY	$55.23 - $63.74 $655,303 - $756,275	11,865	11,865 $756,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wintrust Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wintrust Investments LLC with notifications on news.

Account

Wintrust Investments LLC Bristol Myers Squibb CO Transaction History